BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
284 results:

  • 1. Casitas b cell lymphoma‑B (cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
    Hu X; Li E; Zhou Y; You Q; Jiang Z
    Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term remission of infantile Takayasu arteritis associated with germline cbl syndrome after allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Munoz-Osores E; Piñones M; Barriga F; Wietstruck MA; Pérez-Mateluna G; Mellado C; Aracena M; Parra R; García C; Borzutzky A
    Transpl Immunol; 2024 Apr; 83():102013. PubMed ID: 38395087
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
    Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
    Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive genomic profiling reveals molecular subsets of
    Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
    Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cbl-b negatively regulates TLR/MyD88-mediated anti-
    Wei H; Wu S; Mai L; Yang L; Zou W; Peng H
    Microbiol Spectr; 2023 Dec; 11(6):e0007423. PubMed ID: 37909781
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.
    Jabbour E; Short NJ; Senapati J; Jain N; Huang X; Daver N; DiNardo CD; Pemmaraju N; Wierda W; Garcia-Manero G; Montalban Bravo G; Sasaki K; Kadia TM; Khoury J; Wang SA; Haddad FG; Jacob J; Garris R; Ravandi F; Kantarjian HM
    Lancet Haematol; 2023 Jun; 10(6):e433-e444. PubMed ID: 37187201
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The E3 Ubiquitin Ligase TRIM21 Regulates Basal Levels of PDGFRβ.
    Sarri N; Papadopoulos N; Lennartsson J; Heldin CH
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175489
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Monoclonal B-cell lymphocytosis with a non-CLL immunophenotype - Review of 34 cases.
    Heraud I; Mauduit C; Golfier C; Grange B; Baseggio L
    Ann Biol Clin (Paris); 2023 May; 81(2):162-167. PubMed ID: 37144789
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.
    Wu W; Ren K; Chen X; Li N; Luo Q; Hai T; Zhou H; Zou L
    Cancer Med; 2023 Apr; 12(8):9458-9470. PubMed ID: 37000008
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting cbl-b in cancer immunotherapy.
    Augustin RC; Bao R; Luke JJ
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750253
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Microscopic polyangiitis plasma-derived exosomal miR-1287-5p induces endothelial inflammatory injury and neutrophil adhesion by targeting cbl.
    Zhu Y; Liu L; Chu L; Lan J; Wei J; Li W; Xue C
    PeerJ; 2023; 11():e14579. PubMed ID: 36726727
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [cbl inhibits proliferation and invasion of breast cancer cells by ubiquitylation-mediated degradation of NCK2].
    Song X; Xiao B; Lu J; Zhang W; Li J; Zhu X; Sun Z; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1594-1603. PubMed ID: 36504051
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transient immune deficiency accompanied with homozygous cbl rare variant.
    Morishita A; Yeh TW; Tomari K; Furuichi M; Kashimada K; Morio T; Takagi M; Imai K
    Pediatr Int; 2023 Jan; 65(1):e15439. PubMed ID: 36495474
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by cbl-mediated ubiquitination, and cancer growth.
    Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
    J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrated genome-wide methylation and expression analyses provide predictors of diagnosis and early response to antidepressant in panic disorder.
    Zou Z; Zhang Y; Huang Y; Wang J; Min W; Xiang M; Zhou B; Li T
    J Affect Disord; 2023 Feb; 322():146-155. PubMed ID: 36356898
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immune dysregulation associated with co-occurring germline cbl and SH2B3 variants.
    Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
    Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting the cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
    Monticone G; Huang Z; Csibi F; Leit S; Ciccone D; Champhekar AS; Austin JE; Ucar DA; Hossain F; Ibba SV; Boulares AH; Carpino N; Xu K; Majumder S; Osborne BA; Loh C; Miele L
    Front Immunol; 2022; 13():987298. PubMed ID: 36090975
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
    Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin.
    Ponde NO; Lortal L; Tsavou A; Hepworth OW; Wickramasinghe DN; Ho J; Richardson JP; Moyes DL; Gaffen SL; Naglik JR
    J Biol Chem; 2022 Oct; 298(10):102419. PubMed ID: 36037968
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.